Critical analysis of polycyclic tetramate macrolactam biosynthetic gene cluster phylogeny and functional diversity
Polycyclic tetramate macrolactam (PTM) pathways are frequently found within the genomes of biotechnologically important bacteria, including Streptomyces and Lysobacter spp . Their molecular products are typically bioactive, having substantial agricultural and therapeutic interest. Leveraging bacteri...
Saved in:
Published in | Applied and environmental microbiology Vol. 90; no. 6; p. e0060024 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
18.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Polycyclic tetramate macrolactam (PTM) pathways are frequently found within the genomes of biotechnologically important bacteria, including
Streptomyces
and
Lysobacter
spp
.
Their molecular products are typically bioactive, having substantial agricultural and therapeutic interest. Leveraging bacterial genomics for the discovery of new related molecules is thus desirable, but drawing accurate structural predictions from bioinformatics alone remains challenging. This difficulty stems from a combination of previously underappreciated biosynthetic complexity and remaining knowledge gaps, compounded by a stream of yet-uncharacterized PTM biosynthetic loci gleaned from recently sequenced bacterial genomes. We engaged in the following study to create a useful framework for cataloging historic PTM clusters, identifying new cluster variations, and tracing evolutionary paths for these molecules. Our data suggest new PTM chemistry remains discoverable in nature. However, our metabolomic and mutational analyses emphasize the practical limitations of genomics-based discovery by exposing hidden complexity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Present address: USDA-ARS, New Orleans, Louisiana, USA Present address: Pfizer Inc, Chesterfield, Missouri, USA The authors declare no conflict of interest. Present address: Tulane School of Medicine, New Orleans, Louisiana, USA Present address: Columbia University School of Dental Medicine, New York, New York, USA Christopher P. Harper and Anna Day contributed equally to this article. Author order was determined on the basis of seniority. |
ISSN: | 0099-2240 1098-5336 1098-5336 |
DOI: | 10.1128/aem.00600-24 |